Professor Alex Hewitt

 - Chief Investigator

Research focus: Molecular mechanisms in eye disease

Alex Hewitt is a clinician-scientist. During medical training he completed a B.Med.Sci.(Hons) degree investigating the outcomes of cataract surgery for people living in remote areas of the Northern Territory. In 2001, Alex Hewitt completed his undergraduate medical degree at the University of Tasmania. He obtained his PhD investigating the molecular and phenotypic associations for open angle glaucoma from Flinders University of South Australia in 2009, under the supervision of Professors Jamie Craig and David Mackey. Alex Hewitt completed formal Ophthalmology training at the Royal Victorian Eye and Ear Hospital in Melbourne in 2011, and the following year he was the Novartis Research Fellow at the Lions Eye Institute and was awarded a WA Tall Poppy Award from the Australian Institute of Policy & Science. Alex is currently supported by an NHMRC Practitioner Fellowship.

Alex's main research interests lie in the molecular mechanisms of ocular disease, in particular the blinding disease glaucoma. He has been involved with work relating to the identification of genes and risk variants associated with primary open-angle glaucoma and myopia, as well as quantitative traits such as central corneal thickness, optic nerve size and the retinal microvascular circulation.